TRICLABENDAZOLE SULFOXIDE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C14H9Cl3N2O2S
Molecular Weight	375.657
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TRICLABENDAZOLE SULFOXIDE

Structure Search

SMILES

C[S+]([O-])C1=NC2=C(N1)C=C(OC3=CC=CC(Cl)=C3Cl)C(Cl)=C2

InChI

InChIKey=GABQPFWIQFRJSE-UHFFFAOYSA-N

InChI=1S/C14H9Cl3N2O2S/c1-22(20)14-18-9-5-8(16)12(6-10(9)19-14)21-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)

HIDE SMILES / InChI

Molecular Formula	C14H9Cl3N2O2S
Molecular Weight	375.657
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:57:45 GMT 2025` Edited by `admin` on `Mon Mar 31 19:57:45 GMT 2025`
Record UNII	KY3O5E011U
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CGA-110752

Preferred Name

English

TRICLABENDAZOLE SULFOXIDE

Common Name

English

6-CHLORO-5-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFINYL)-1H-BENZIMIDAZOLE

Systematic Name

English

1H-BENZIMIDAZOLE, 6-CHLORO-5-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFINYL)-

Systematic Name

English

TRICLABENDAZOLE FOR VETERINARY USE IMPURITY A [EP IMPURITY]

Common Name

English

5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFINYL)-1H-BENZIMIDAZOLE

Systematic Name

English

CGP023031

Common Name

English

TRICLABENDAZOLE METABOLITE M7

Common Name

English

Code System Code Type Description

FDA UNII

KY3O5E011U

Created by admin on Mon Mar 31 19:57:45 GMT 2025 , Edited by admin on Mon Mar 31 19:57:45 GMT 2025

PRIMARY

CAS

100648-13-3

Created by admin on Mon Mar 31 19:57:45 GMT 2025 , Edited by admin on Mon Mar 31 19:57:45 GMT 2025

PRIMARY

EPA CompTox

DTXSID80905640

Created by admin on Mon Mar 31 19:57:45 GMT 2025 , Edited by admin on Mon Mar 31 19:57:45 GMT 2025

PRIMARY

RS_ITEM_NUM

1681622

Created by admin on Mon Mar 31 19:57:45 GMT 2025 , Edited by admin on Mon Mar 31 19:57:45 GMT 2025

PRIMARY

PUBCHEM

127657

Created by admin on Mon Mar 31 19:57:45 GMT 2025 , Edited by admin on Mon Mar 31 19:57:45 GMT 2025

PRIMARY

Related Record Type Details


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					0UY97CSG1T

CYTOCHROME P450 2B6

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> SUBSTRATE


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					PD6N2O0M3A

FASCIOLA GIGANTICA

TARGET ORGANISM->INHIBITOR


					246D9TQ2XG

CYTOCHROME P450 2A6

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					DT53URI4O9

FASCIOLA HEPATICA

TARGET ORGANISM->INHIBITOR


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:

Related Record Type Details


					4784C8E03O

TRICLABENDAZOLE

PARENT -> METABOLITE ACTIVE

Interaction Type:

MAJOR

Qualification:

PLASMA

Related Record Type Details


					4784C8E03O

TRICLABENDAZOLE

PARENT -> IMPURITY

Comments:

FOR VETERINARY USE

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC